164 related articles for article (PubMed ID: 33089141)
1. Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis.
Alvarez Nadal M; Sosa Barrios RH; Burguera Vion V; Campillo Trapero C; Fernández Lucas M; Rivera Gorrín ME
Kidney Med; 2020; 2(5):650-651. PubMed ID: 33089141
[TBL] [Abstract][Full Text] [Related]
2. Relapsing peritonitis and taurolidine peritoneal catheter lock: One center experience.
Sosa Barrios RH; Álvarez Nadal M; Burguera Vion V; Campillo Trapero C; López Melero E; Fernández Lucas M; Rivera Gorrín ME
J Vasc Access; 2021 Mar; 22(2):261-265. PubMed ID: 32605474
[TBL] [Abstract][Full Text] [Related]
3. EDTA and Taurolidine Affect Pseudomonas aeruginosa Virulence
Colombari B; Alfano G; Gamberini C; Cappelli G; Blasi E
Microbiol Spectr; 2021 Dec; 9(3):e0104721. PubMed ID: 34787464
[TBL] [Abstract][Full Text] [Related]
4. Taurolidine as adjuvant treatment of relapsing peritonitis in peritoneal dialysis patients.
Klimek K; Aresté Fosalba N; Ramírez López MÁ; Gómez Castilla AC; Salgueira Lazo M
Nefrologia (Engl Ed); 2020; 40(2):197-201. PubMed ID: 31208832
[TBL] [Abstract][Full Text] [Related]
5. A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients.
Zwiech R; Adelt M; Chrul S
Am J Ther; 2016; 23(2):e363-8. PubMed ID: 23665885
[TBL] [Abstract][Full Text] [Related]
6. Extended Experience in the Use of Antibiotic Lock for Eradication of Biofilm Bacteria on Tenckhoff Catheter.
Wong SS; Lau WY; Chan PK; Wan CK; Cheng YL
Perit Dial Int; 2019; 39(2):187-190. PubMed ID: 30858288
[TBL] [Abstract][Full Text] [Related]
7. Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis.
Gallieni M; Chiarelli G; Olivi L; Cozzolino M; Cusi D
Clin Nephrol; 2011 Jan; 75(1):70-3. PubMed ID: 21176753
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic Lock in Tenckhoff Catheter for Biofilm-Associated Peritonitis.
Wong SS; Lau WY; Chan PK; Wan CK; Cheng YL
Perit Dial Int; 2017; 37(4):475-477. PubMed ID: 28676513
[TBL] [Abstract][Full Text] [Related]
9. Salvage of the peritoneal dialysis catheter in
van Eck van der Sluijs A; Eekelschot KZ; Frakking FN; Haas PA; Boer WH; Abrahams AC
Perit Dial Int; 2021 Jan; 41(1):110-114. PubMed ID: 32400305
[No Abstract] [Full Text] [Related]
10. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
Betjes MG; van Agteren M
Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
[TBL] [Abstract][Full Text] [Related]
11. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
[TBL] [Abstract][Full Text] [Related]
12. Taurolidine and Heparin as Catheter Lock Solution for Central Venous Catheters in Hemodialysis.
Nguyen T; Camins BC; Butler DA
Am J Ther; 2024 May; ():. PubMed ID: 38710029
[TBL] [Abstract][Full Text] [Related]
13. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
[TBL] [Abstract][Full Text] [Related]
14. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
15. Role of intraperitoneal urokinase in acute peritonitis and prevention of catheter loss in peritoneal dialysis patients.
Gadallah MF; Tamayo A; Sandborn M; Ramdeen G; Moles K
Adv Perit Dial; 2000; 16():233-6. PubMed ID: 11045301
[TBL] [Abstract][Full Text] [Related]
16. [Peritoneal dialysis-related eosinophilic peritonitis: a case report and literature review].
Tsai SM; Yan Y; Zhao HP; Wu B; Zuo L; Wang M
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):747-751. PubMed ID: 30122784
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and cause of removal of peritoneal dialysis catheter in patients on continuous ambulatory peritoneal dialysis.
Nodaira Y; Ikeda N; Kobayashi K; Watanabe Y; Inoue T; Gen S; Kanno Y; Nakamoto H; Suzuki H
Adv Perit Dial; 2008; 24():65-8. PubMed ID: 18986004
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Catheter Replacement for Infectious and Mechanical Complications Without Interruption of Peritoneal Dialysis.
Crabtree JH; Siddiqi RA
Perit Dial Int; 2016; 36(2):182-7. PubMed ID: 26429420
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous removal and replacement of the peritoneal catheter in CAPD patient with refractory peritonitis sustained by P. aeruginosa: A case-report.
Nardelli L; Scalamogna A; Moscardino S; Tripodi F; Vettoretti S; Alfieri C; Castellano G
J Vasc Access; 2023 May; ():11297298231178061. PubMed ID: 37249054
[TBL] [Abstract][Full Text] [Related]
20. Outcome of patients on chronic peritoneal dialysis undergoing peritoneal catheter removal because of peritonitis.
Troidle L; Gorban-Brennan N; Finkelstein FO
Adv Perit Dial; 2005; 21():98-101. PubMed ID: 16686295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
